Clinical studies have shown that severely ill patients with COVID-19 have a high demand for insulin during peak inflammatory responses, and this significant increase in insulin demand may be due to systemic inflammation and severe IR due to critical illness (73, 74). This evidence concerns the gene INS and COVID-19.